Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
grade D 19.63 -3.11% -0.63
NVTA closed down 3.11 percent on Friday, January 17, 2020, on 1.18 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical NVTA trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New Uptrend Bullish -3.11%
Pocket Pivot Bullish Swing Setup -3.11%
Calm After Storm Range Contraction -3.11%
Upper Bollinger Band Walk Strength -3.11%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Medicine Cancer Biology Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Genetic Disorders Neurology Genetic Disorder Cardiovascular Disorders

Is NVTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.75
52 Week Low 13.0
Average Volume 1,943,795
200-Day Moving Average 20.60
50-Day Moving Average 17.62
20-Day Moving Average 17.03
10-Day Moving Average 17.74
Average True Range 0.97
ADX 27.47
+DI 32.01
-DI 10.39
Chandelier Exit (Long, 3 ATRs ) 17.49
Chandelier Exit (Short, 3 ATRs ) 18.02
Upper Bollinger Band 19.76
Lower Bollinger Band 14.30
Percent B (%b) 0.98
BandWidth 32.07
MACD Line 0.50
MACD Signal Line 0.01
MACD Histogram 0.4927
Fundamentals Value
Market Cap 854.78 Million
Num Shares 43.5 Million
EPS -2.73
Price-to-Earnings (P/E) Ratio -7.19
Price-to-Sales 9.34
Price-to-Book 5.59
PEG Ratio -0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.98
Resistance 3 (R3) 21.09 20.74 20.76
Resistance 2 (R2) 20.74 20.40 20.69 20.68
Resistance 1 (R1) 20.19 20.19 20.02 20.08 20.60
Pivot Point 19.84 19.84 19.76 19.79 19.84
Support 1 (S1) 19.29 19.50 19.12 19.18 18.66
Support 2 (S2) 18.94 19.29 18.89 18.58
Support 3 (S3) 18.39 18.94 18.51
Support 4 (S4) 18.28